1. Clinical Data Interchange Standards Consortium. http://www.cdisc.org/mission-and-principles.
2. Food and Drug Administration. Guidance for clinical trial sponsors: establishment and operation of clinical trial data monitoring committees, section 4.2.2. March 2006. http://www.fda.gov/OHRMS/DOCKETS/98fr/01d-O489-gdl0003.pdf.
3. O’Neill R. Signal detection in clinical trials: some perspectives on new tools and processes—a critical path update. 19th DIA Annual Euromeeting. Vienna, Austria, March 26–28, 2007.
4. Food and Drug Administration. Guidance for industry: adaptive design clinical trials for drugs and biologics. February 2010. http://www.fda.gov/downloads/Drugs/guidancecomplianceregulatoryinformation/guidances/ucm201790.pdf.
5. Food and Drug Administration. Guidance for industry: part 11: electronic records: electronic signatures—scope and application. August 2003. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070295.pdf.